Influencers, Dangerous Peptides & Regulatory Challenges

Fitness influencers, some of whom have millions of followers and harness great social power, are increasingly presenting peptides as modern self-improvement tools.

They often draw their followers in with dramatic before and after photos and claims these peptide products improve energy, recovery, physique and performance. Content is framed as personal experience. This gives the impression of authenticity and trustworthiness.

But behind much of this content sits a sophisticated affiliate marketing system.

Influencers frequently provide personalised discount codes, offering followers between 5% and 30% off purchases. Each click redirects buyers to online peptide vendors, generating commission for the influencer. Trust, attention and admiration are converted directly into revenue.

This matters because it fundamentally blurs the boundary between personal recommendation and commercial advertising. Followers may perceive influencers to be relatable peers sharing genuine experiences – rather than salespeople who have a financial incentive to drive sales.

Influencer sponsorship arrangements are often vague, poorly disclosed or hidden entirely. This is a concern, given advertising standards and many social media platforms state that commercial partnerships must be explicitly disclosed.

At the same time, platform algorithms intensify the problem. Sophisticated algorithms learn from users’ behavioural patterns and predictively direct content based on prior engagement, interactions and viewing habits.

In doing so, the platform feeds users with peptide promotions, transformation videos and enhancement-focused accounts. Social media users quickly become immersed in these digital environments, where peptides appear normal and safe to use.

Injectable peptides are re-framed by influencers as routine and essential tools of self-optimisation. Yet the influencers promoting these products often have no relevant medical qualifications. Consumers may therefore not realise the risks of using unlicensed peptides and the harm they can cause.

Worryingly, young people may be particularly vulnerable to harms, given their high exposure to online enhancement cultures and reduced comprehension of risk.

Currently, unapproved peptide sales sit in a difficult enforcement space. This is shaped by legal loopholes, resource constraints, evidentiary burdens and regulatory priorities.

One way online peptides vendors attempt to sidestep medicine and consumer protection laws is through how products are labelled. Many peptide products are labelled as being designed for “research purposes” or “not for human consumption”.

But these disclaimers aren’t really intended to be genuine safety warnings for consumers. Rather, they act as legal positioning. The label allows sellers to distance themselves from therapeutic claims while continuing to profit from products.

The regulatory challenge is equally substantial. In the UK alone, responsibility spans the Medicines and Healthcare products Regulatory Agency, Advertising Standards Authority, Competition and Markets Authority, Trading Standards and Ofcom. Social media platforms also have their own advertising and safety policies.

This matters because no single regulator fully owns the peptide market. Responsibility is spread across multiple agencies, making enforcement slow and fragmented while the market rapidly expands. This is particularly problematic when vendors operate anonymously or offshore, as it further fragments responsibility and enforcement.

At the same time, influencers are accelerating demand faster than regulators can respond. The market is also becoming increasingly industrialised, with influencers providing YouTube tutorials on how to set up your own peptide business and targeted adverts encouraging new peptide entrepreneurs.

This makes it possible for anyone to start a fully operating business, complete with supplier networks, fulfilment systems, branding kits, website templates and social media marketing strategies. This dramatically lowers barriers to entry for new online vendors. It means anyone – even those with no medical or scientific qualifications – can promote and sell these products.

The online peptide market is expanding faster than regulators can keep up. Influencers and sophisticated affiliate marketing systems are partly to blame. It’s imperative that regulatory bodies begin investigating these issue fast to prevent consumers from being harmed.

This article is republished from The Conversation under a Creative Commons license. Read the original article.